Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.68 |
| ▸ | CCR5 | P51681 | 2/20 | 0.68 |
| ▸ | CCR8 | P51685 | 2/20 | 0.68 |
| ▸ | NOS2 | P35228 | 3/20 | 0.52 |
| ▸ | NOS3 | P29474 | 2/20 | 0.52 |
| ▸ | NOS1 | P29475 | 2/20 | 0.52 |
| ▸ | METAP2 | P50579 | 1/20 | 0.49 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.39 |
| ▸ | JMJD6 | Q6NYC1 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31279599 | 0.89 | NOS3 (0.61) | CCR1CCR5CCR8NOS2NOS3 | |
| SCHEMBL913143 | 0.89 | NOS3 (0.61) | CCR1CCR5CCR8NOS2NOS3 | |
| SCHEMBL17132035 | 0.89 | CCR1 (0.63) | CCR1CCR5CCR8NOS2NOS3 | |
| SCHEMBL23037127 | 0.86 | CCR1 (0.71) | CCR1CCR5CCR8NOS2NOS3 | |
| SCHEMBL29693673 | 0.86 | CCR1 (0.71) | CCR1CCR5CCR8NOS2NOS3 | |
| SCHEMBL15082607 | 0.86 | CCR1 (0.71) | CCR1CCR5CCR8NOS2NOS3 | |
| SCHEMBL181893 | 0.82 | CCR1 (1.00) | CCR1CCR5CCR8NOS2NOS3 | |
| SCHEMBL29397106 | 0.82 | CCR1 (1.00) | CCR1CCR5CCR8NOS2NOS3 | |
| SCHEMBL5468413 | 0.82 | CCR1 (0.65) | CCR1CCR5CCR8NOS2NOS3 | |
| SCHEMBL29680018 | 0.82 | CCR1 (0.65) | CCR1CCR5CCR8NOS2NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11031237-B2 | Aromatic amino siloxane functionalized materials for use in capping porous dielectrics | MERCK PATENT GMBH (DE) | 2021-06-08 | — | — | US | disclosed |
| US-20200273701-A1 | AROMATIC AMINO SILOXANE FUNCTIONALIZED MATERIALS FOR USE IN CAPPING POROUS DIELECTRICS | EMD PERFORMANCE MATERIALS CORPORATION | 2020-08-27 | — | — | US | disclosed |
| EP-2231900-B1 | MONOLITHIC CATALYST SYSTEM FOR THE PHOTOLYSIS OF WATER | CFSO GMBH (DE) | 2019-06-12 | — | — | EP | disclosed |
| US-8883671-B2 | Monolithic catalyst system for the photolysis of water | CFSO GMBH (DE) | 2014-11-11 | — | — | US | disclosed |
| US-8883671-B2 | Monolithic catalyst system for the photolysis of water | CFSO GMBH (DE) | 2014-11-11 | — | — | US | disclosed |
| US-20110220484-A1 | MONOLITHIC CATALYST SYSTEM FOR THE PHOTOLYSIS OF WATER | CFSO GMBH (DE) | 2011-09-15 | — | — | US | disclosed |
| US-20110220484-A1 | MONOLITHIC CATALYST SYSTEM FOR THE PHOTOLYSIS OF WATER | CFSO GMBH (DE) | 2011-09-15 | — | — | US | disclosed |
| US-7411053-B2 | Ligand-functionalized/azo compounds and methods of use thereof | HARRUNA ISSIFU I | 2008-08-12 | — | — | US | disclosed |
| US-7411053-B2 | Ligand-functionalized/azo compounds and methods of use thereof | HARRUNA ISSIFU I | 2008-08-12 | — | — | US | disclosed |
| US-20070276104-A1 | LIGAND-FUNCTIONALIZED/AZO COMPOUNDS AND METHODS OF USE THEREOF | HARRUNA ISSIFU I | 2007-11-29 | — | — | US | disclosed |
| US-20070276104-A1 | LIGAND-FUNCTIONALIZED/AZO COMPOUNDS AND METHODS OF USE THEREOF | HARRUNA ISSIFU I | 2007-11-29 | — | — | US | disclosed |
| US-5874587-A | FLUORESCENCE | THE ROCKEFELLER UNIVERSITY (US) | 1999-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11031237-B2 | Aromatic amino siloxane functionalized materials for use in capping porous dielectrics | ZYX, YBX1, CDYL | CCR1 2442/4885CCR5 2686/4885CCR8 3043/4885 |
| US-20070276104-A1 | LIGAND-FUNCTIONALIZED/AZO COMPOUNDS AND METHODS OF USE THEREOF | FLT3, ALK, NECTIN4 | CCR1 204/4885CCR5 210/4885CCR8 124/4885 |
| US-20200273701-A1 | AROMATIC AMINO SILOXANE FUNCTIONALIZED MATERIALS FOR USE IN CAPPING POROUS DIELECTRICS | ZYX, YBX1, CDYL | CCR1 2442/4885CCR5 2686/4885CCR8 3043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.